person

Vanesa P. A.

Country
Spain
Department
Department of pediatrics hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
158
Sites with multiple studies

Has run more than one trial at 158 of 251 partner sites.

Specializations

Hematological Disorders

This investigator specializes in treating paroxysmal nocturnal hemoglobinuria (PNH), with particular emphasis on adolescent patient populations aged 12-17 years. Their research focuses on innovative therapeutic approaches for managing this rare blood disorder.

  • Blood disorder management
  • Adolescent hematology
  • Rare disease therapeutics

Their expertise extends to monitoring hemoglobin levels and lactate dehydrogenase markers in blood disorders.

Clinical Pharmacology

The investigator's work involves studying pharmacokinetics of novel treatments in adolescent populations. Their research encompasses evaluation of biological activity and therapeutic responses in young patients.

  • Drug metabolism studies
  • Therapeutic monitoring
  • Pediatric drug development

Their approach includes comprehensive assessment of treatment efficacy and safety profiles in younger patient groups.

Safety Monitoring

The investigator focuses on treatment-emergent adverse events monitoring, with particular attention to bacterial infection risks in immunocompromised patients. Their work includes systematic evaluation of therapeutic safety in adolescent populations.

  • Infection surveillance
  • Adverse event monitoring
  • Patient safety protocols

They specialize in developing comprehensive safety assessment protocols for novel therapeutic interventions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.